Cancer Prevention Research Institute of Texas

• NCT07783659

  Collaborator, Phase 1, Not yet recruiting, 24 people, 25 Aug 2026

• A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC)

  Collaborator, Phase 2, Active, not recruiting, 10 people, 29 Feb 2024

• NCT05431595

  Collaborator, Phase 2/3, Recruiting, 42 people, 24 Jun 2022

• NCT04614194

  Collaborator, Phase 2, Recruiting, 60 people, 3 Nov 2020

• NCT04200534

  Collaborator, Early phase 1, Active, not recruiting, 358 people, 16 Dec 2019

• NCT03747042

  Collaborator, Phase 2, Completed, 61 people, 20 Nov 2018

• NCT02932956

  Collaborator, Phase 1, Active, not recruiting, 10 people, 13 Oct 2016

• NCT02905188

  Collaborator, Phase 1, Completed, 9 people, 19 Sept 2016

• NCT02423915

  Collaborator, Phase 1, Completed, 5 people, 22 Apr 2015

Sources: clinicaltrials.gov

• Feasibility of a brief sequential sleep and physical activity behavioral intervention in African American adults with overweight or obesity

  RP-170259, 7 Jan 2026

Sources: pubmed.ncbi.nlm.nih.gov